In zebrafish, ketamine causes changes a brain circuit involved in "giving up." That may help explain how the drug helps ...

The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...

Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

Patients who received the drug, called navacaprant, showed no more improvement in depressive symptoms than people who ...

Purpose: The association of antipsychotic and antidepressant drugs with Q-T interval prolongation is reviewed. Summary: Prolongation of the Q-T interval can be of particular concern to ...

The study, first of the three late-stage trials, was testing the drug, navacaprant, in patients with major depressive ...

Studies show that antidepressants don’t always work. One psychologist explains how to take control of negative thoughts ...

Neumora Therapeutics, Inc. (NASDAQ:NMRA) stock traded lower after the company released data from the Phase 3 KOASTAL-1 Study ...

New York, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Overview: The Antidepressant Drugs Market size is expected to reach USD 20.1 billion by 2024 and is further anticipated to reach USD 26.9 billion by ...

Despite being a first-line treatment for adolescent depression and anxiety, antidepressant drugs appear to have questionable efficacy and carry an increased risk of adverse effects in this population.

If you or a loved one is struggling with anxiety or depression, contact the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 800-662-4357 for information on ...